327 related articles for article (PubMed ID: 22907887)
21. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
[TBL] [Abstract][Full Text] [Related]
22. Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor types.
Schwaederle M; Elkin SK; Tomson BN; Carter JL; Kurzrock R
Cell Cycle; 2015; 14(14):2355-61. PubMed ID: 26030731
[TBL] [Abstract][Full Text] [Related]
23. Search for mutations in signaling pathways in head and neck squamous cell carcinoma.
De Carvalho TG; De Carvalho AC; Maia DC; Ogawa JK; Carvalho AL; Vettore AL
Oncol Rep; 2013 Jul; 30(1):334-40. PubMed ID: 23670291
[TBL] [Abstract][Full Text] [Related]
24. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma.
Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ
Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications.
Hunt JL; Barnes L; Lewis JS; Mahfouz ME; Slootweg PJ; Thompson LD; Cardesa A; Devaney KO; Gnepp DR; Westra WH; Rodrigo JP; Woolgar JA; Rinaldo A; Triantafyllou A; Takes RP; Ferlito A
Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):211-23. PubMed ID: 23467835
[TBL] [Abstract][Full Text] [Related]
26. Sequencing the head and neck cancer genome: implications for therapy.
Sun W; Califano JA
Ann N Y Acad Sci; 2014 Dec; 1333():33-42. PubMed ID: 25440877
[TBL] [Abstract][Full Text] [Related]
27. Cancers of the upper gastro-intestinal tract: a review of somatic mutation distributions.
Abedi-Ardekani B; Hainaut P
Arch Iran Med; 2014 Apr; 17(4):286-92. PubMed ID: 24724606
[TBL] [Abstract][Full Text] [Related]
28. Identification of genomic mutations associated with clinical outcomes of induction chemotherapy in patients with head and neck squamous cell carcinoma.
Ock CY; Son B; Keam B; Lee SY; Moon J; Kwak H; Kim S; Kim TM; Jeon YK; Kwon SK; Hah JH; Lee SH; Kwon TK; Kim DW; Wu HG; Sung MW; Heo DS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):873-83. PubMed ID: 26677030
[TBL] [Abstract][Full Text] [Related]
29. Involvement of the p53-p16/RB pathway control mechanism in early-stage carcinogenesis in head and neck squamous cell carcinoma.
Mori T
Pathol Int; 2022 Dec; 72(12):577-588. PubMed ID: 36218243
[TBL] [Abstract][Full Text] [Related]
30. Unraveling most abundant mutational signatures in head and neck cancer.
Plath M; Gass J; Hlevnjak M; Li Q; Feng B; Hostench XP; Bieg M; Schroeder L; Holzinger D; Zapatka M; Freier K; Weichert W; Hess J; Zaoui K
Int J Cancer; 2021 Jan; 148(1):115-127. PubMed ID: 32930393
[TBL] [Abstract][Full Text] [Related]
31. Genomic profiles of Japanese patients with vulvar squamous cell carcinoma.
Fujii E; Kato MK; Yamaguchi M; Higuchi D; Koyama T; Komatsu M; Hamamoto R; Ishikawa M; Kato T; Kohno T; Shiraishi K; Yoshida H
Sci Rep; 2024 Jun; 14(1):13058. PubMed ID: 38844774
[TBL] [Abstract][Full Text] [Related]
32. Homozygous deletions of UGT2B17 modifies effects of smoking on TP53-mutations and relapse of head and neck carcinoma.
Mafune A; Hama T; Suda T; Suzuki Y; Ikegami M; Sakanashi C; Imai S; Nakashima A; Yokoo T; Wada K; Kojima H; Urashima M
BMC Cancer; 2015 Mar; 15():205. PubMed ID: 25886176
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.
Er TK; Wang YY; Chen CC; Herreros-Villanueva M; Liu TC; Yuan SS
Oral Dis; 2015 Oct; 21(7):872-8. PubMed ID: 26173098
[TBL] [Abstract][Full Text] [Related]
34. Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
Al-Amri AM; Vatte C; Cyrus C; Chathoth S; Hashim TM; Mohamed YS; Al Ali R; Alsaid A; Al Ali A
Cancer Biomark; 2016; 16(3):377-83. PubMed ID: 26889984
[TBL] [Abstract][Full Text] [Related]
35. Molecular and IHC analysis of head and neck carcinomas associated with HPV infection.
Stanek L; Glendova K; Tesarova P; Gurlich R; Holeckova P; Musil Z; Hrudka J; Pala M; Mateicka F; Chovanec M
Bratisl Lek Listy; 2019; 120(11):832-838. PubMed ID: 31747763
[TBL] [Abstract][Full Text] [Related]
36. Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer.
Deneka AY; Baca Y; Serebriiskii IG; Nicolas E; Parker MI; Nguyen TT; Xiu J; Korn WM; Demeure MJ; Wise-Draper T; Sukari A; Burtness B; Golemis EA
Clin Cancer Res; 2022 May; 28(9):1925-1937. PubMed ID: 35491653
[TBL] [Abstract][Full Text] [Related]
37. Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.
Todorova TA; Jordanov SH; Stancheva GS; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
Pathol Oncol Res; 2015 Apr; 21(2):413-21. PubMed ID: 25149524
[TBL] [Abstract][Full Text] [Related]
38. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
39. Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies.
Wirtz ED; Hoshino D; Maldonado AT; Tyson DR; Weaver AM
JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):543-9. PubMed ID: 25855885
[TBL] [Abstract][Full Text] [Related]
40. Mutation frequency in 15 common cancer genes in high-risk head and neck squamous cell carcinoma.
McBride SM; Rothenberg SM; Faquin WC; Chan AW; Clark JR; Ellisen LW; Wirth LJ
Head Neck; 2014 Aug; 36(8):1181-8. PubMed ID: 23852799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]